Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Year Ended December 31, 2015
24. Februar 2016 07:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Feb. 24, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial stage pharmaceutical company focused on developing,...
Parnell to Report Financial Results for Fiscal Year 2015 on February 24, 2016
18. Februar 2016 08:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Feb. 18, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
UPDATE -- Parnell Pharmaceuticals Holdings Ltd Announces Agreement With Lincoln Park Capital Fund to Purchase Ordinary Shares
20. Januar 2016 13:01 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kansas, Jan. 20, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. ("Parnell" or "Company") (NASDAQ:PARN), a fully integrated pharmaceutical company focused on...
Parnell Pharmaceuticals Holdings Ltd Announces Agreement With Lincoln Park Captial Fund to Purchase Ordinary Shares
19. Januar 2016 17:15 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kansas, Jan. 19, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. ("Parnell" or "Company") (NASDAQ:PARN), a fully integrated pharmaceutical company focused on...
Parnell Pharmaceuticals Holdings Ltd to Present at Biotech Showcase Conference in San Francisco
11. Januar 2016 10:01 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kansas, Jan. 11, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Appoints Ellen B. Richstone and Dr. David K. Rosen to the Board of Directors
17. Dezember 2015 11:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kansas, Dec. 17, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (Nasdaq:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd to Present at Jefferies 2015 Global Healthcare Conference in London
18. November 2015 08:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kansas, Nov. 18, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd Announces Third Quarter Business Results
21. Oktober 2015 07:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kansas, Oct. 21, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing,...
Parnell to Report Financial Results for the Nine Months Ended September 30, 2015 on October 21, 2015
09. Oktober 2015 13:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kansas, Oct. 9, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (NASDAQ:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd Restructures Board
09. Oktober 2015 11:00 ET
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kansas, Oct. 9, 2015 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated pharmaceutical company focused on developing, manufacturing and...